Device Trial Radar · NCT00874835
Corneal Endothelium Delivery Instrument
Last checked: Nov 20, 2026Latest source record: May 7, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Mar 2009
Primary completion
Oct 2010
Study completion Oct 2010
Sponsor
- Lead sponsor
- Ocular Systems, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Wake Forest University
- First posted
- Apr 3, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the surgical outcomes in patients undergoing Descemet's Stripping Endothelial Keratoplasty (DSEK) are improved with the use of an insertion device over the traditional forceps insertion method.
Conditions
- Corneal Transplantation
Interventions
EndoSaver™ Corneal Endothelium Delivery InstrumentDevice
Efficacy of device to maintain function and integrity of corneal endothelial cells during insertion into the eye during keratoplasty.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 6-month post-operative endothelial cell densityTime frame: 6-months post-operatively
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Wake Forest University Eye Center
Winston-Salem, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.